¹ï¥I¡uëC³Â¯l¡v¶¼­¹­­¨î¨Ã«D¸t¦®¡IÂå¡G»ÝÂç²M¯fªp

2022-07-18 1375

·¨­õ¤å»¡©ú¡A«æ©ÊëC³Â¯l¬ù¦³2¦¨¦hªº¯f±w¬O­¹ª«¤Þ°_¡F­Y¬OºC©ÊëC³Â¯l¡A¯u¥¿¥Ñ­¹ª«¹L±Ó¤Þ°_ªº¤ñ¨Ò«D±`¤Ö¡C

ëC³Â¯l¬OÁ{§É±`¨£¥Ö½§¯e¯f¡A¦ýÁ{§ÉªvÀø±`±`¹L©ó¸gÅç©Ê¦Ó¤£°÷¦³¹êÃÒÂå¾Ç¦õÃÒ¡A¥xÆW¥Ö½§¬ìÂå¾Ç·|©ó2021¦~µoªí³Ì·sª©ªºëC³Â¯lªvÀø¦@ÃÑ¡C°ê®õºî¦XÂå°|¡B¤º´ò°ê®õ¶E©Ò¥Ö½§¬ì¥DªvÂå®v·¨­õ¤åªí¥Ü¡AëC³Â¯lªº©w¸q¬O¬ðµo©Ê­·¯l¶ô¡]wheals¡^¡B¦åºÞ©Ê¤ô¸~¡]angioedema¡^¡A©Î¨âªÌ­Ý¨ã¡C

·¨­õ¤å»¡©ú¡A­·¯l¶ô³q±`¨ã¦³¤T¶µ¯S¦â¡A²Ä¤@¨S¦³ªí¥ÖÅܤƦUºØ¤j¤pªº¸~¶ô¡A¦³®É·|³Q¤Ï®g©Ê¬õ´³Àô¶¡F²Ä¤GµoÄo¡A°¸º¸¥X²{³Â¨ë·P¡B¨`¼ö·P¡F²Ä¤T¡A¥Ö½§³q±`¦b24¤p®É¤º·|«ì´_¥¿±`¥~Æ[¡C¦Ü©ó¦åºÞ©Ê¤ô¸~¡A°£¤FÄo·P¤§¥~ÁÙ¥i¯à¦ñÀH¯kµhªº·Pı¡A½w¸Ñ³t«×¤ñ­·¯l¶ôºC¡A¥i¯à·|ºû«ùªø¹F72¤p®É¡C

6¶µ¯f¥v°Ýµª¡@À°§UÂå®v¤F¸Ñ¯f¦]

¨Ì¾Ú­·¯l¶ô¡B¦åºÞ©Ê¤ô¸~ªº«ùÄò®É¶¡¡A¯e¯fºû«ù®É¶¡¤p©ó6¶g¬°«æ©ÊëC³Â¯l¡A¶W¹L6¶g«h©w¸q¬°ºC©ÊëC³Â¯l¡C·¨­õ¤åªí¥Ü¡A«æ©Ê³Â¯l±`¨£ªº­P¯f¦]¯À¬°­¹ª«¡BÃĪ«¤Î·P¬V¡A¦ý¦Ûµo©ÊµL©úÅã¯f¦]ªÌ¤]¤£¤Ö¨£¡C¥Ø«e¤wµo²{³\¦hºC©ÊëC³Â¯l¯f²z¥Í²z¾Ç¬ÛÃö¦]¤l¡A³\¦h¯f¦]³£¤£¬O¹L±Ó­ìÀË´ú¥i¥HÀˬd¥X¨Ó ¡C

·¨­õ¤å«ü¥X¡A¥Á²³´NÂå®ÉÂå®v·|¸ß°Ý¥H¤U¯f¥v¡A­YÁ{§É§PÂ_¦³»Ý­nÂç²M¤§³B¦A¦w±Æ¦X²zªºÀËÅç©ÎÀˬd¡C

1.¬O§_¦³«DÃþ©T¾J®øª¢¤îµhÃÄ(NSAID) ¹L±Ó¡A¬O§_¦]¦åºÞ¦¬ÁY¯ÀÂà´«酶 (ACE) §í¨î¾¯»¤µo¡A¤Ö¼Æ¯f±w¥ç¥i¯à»P¹w¨¾±µºØ¡B²üº¸»X¡BÂm¾¯¡B®ê¾¯¡B¦Õ©M²´³¡ºw¾¯¡B´À¥NÀøªk©Î¤¤Ãĵ¥¦³Ãö¡H

2.¬O§_»P­¹ª«©M°sºë¶¼®Æ¬ÛÃö¡A¬O§_¹ï­¹ª«¦³°²©Ê¹L±Ó¡]pseudoallergic) ¤ÏÀ³¡H

3.¬O§_¦³¦ÛÅé§K¬Ì¯e¯f¡H

4.¬O§_¦³¥i¯à¬ÛÃöªº¸z­G¹D¯e¯f¡]¨Ò¦p«ÕªùÁ³±Û±ìµß©Î®üÃ~­G½uÂΡ^¡H

5.¬O§_¦]ª«²z¦]¯À¡]¦p§N¡B¼ö¾_°Ê¡^©Î¹B°Ê»¤µo¡H

6.¤â³N´Ó¤Jª«¤Î¤â³N¤¤¬O§_´¿µo¥ÍëC³Â¯l¡H

¶¼­¹­­¨î¨Ã«D¸t¦®¡I¦]­¹ª«¤Þ°_ªººC©ÊëC³Â¯l¤ñ¨Ò¸û§C

°w¹ïëC³Â¯l¬O§_»Ý¶i¦æ¶¼­¹­­¨î¡A·¨­õ¤å»¡©ú¡A»Ý­nÂç²M¯f±w¬O«æ©Ê©ÎºC©ÊëC³Â¯l¡A«æ©ÊëC³Â¯l¬ù¦³2¦¨¦hªº¯f±w¬O­¹ª«¤Þ°_¡F­Y¬OºC©ÊëC³Â¯l¡A¯u¥¿¥Ñ­¹ª«¹L±Ó¤Þ°_ªº¤ñ¨Ò«D±`¤Ö¡A¤£«Øij¹ï¤j³¡¤À¯f±w°µ¤Ó¼sªx¥BµL®Ú¾Úªº­¹ª«­­¨î¡F¹ï©ó¯S©wºC©ÊëC³Â¯l¯f±w¡A¯f±¡¤j©ó¨â¦~¥B¦X¨Ö¸z­G¹D¯gª¬¡]¦p¸¡µÈ¡B¸¡Âm¡^¡A¨Ï¥Î§C²Õ´Ói¶¼­¹Àøªk3¶g¥H¤W¡A«h¥i¥H¨Ï6¦¨ªº¯f±wÀò±o§ïµ½¡C

«æ©Ê»PºC©ÊëC³Â¯lªvÀø®t²§

ªñ¦~¨Ó¡A«æ©ÊëC³Â¯lªºªvÀø¨S¦³¤Ó¤j§ïÅÜ¡A·¨­õ¤åªí¥Ü¡A²Ä¤@½uªvÀø¬O§Ü²Õ´Ói¡]²Ä¤@¥N©Î²Ä¤G¥N¡^¡A­Y¯gª¬«ÜÄY­«¥B¦b±µ¨ü§Ü²Õ´Ói«á¥¼¨£½w¸Ñ¡A¥i¦Ò¼{¹Á¸Õµu®É¶¡ ¡]¬ù3-5¤Ñ¡^¤fªA¥Ö½èÃþ©T¾JªvÀø¡AÁöµMÁ{§É¤W³\¦hÂå®v±`±`²Ä¤@½u§Yµ¹¤©¤fªAÃþ©T¾J¡A¦ý»Ý¤F¸Ñ±`³W¨Ï¥Î¤fªA¥Ö½èÃþ©T¾J¹ï«æ©ÊëC³Â¯lªº®Ä¯q¡F·í¯f±wªí²{ÄY­«©I§l¹D¡B¤ßŦ©Î¸z­G¹D¯gª¬®É¡A«hÀ³¸Ó¦b²Ä¤@½u¨Ï¥ÎµÇ¤W¸¢¯ÀªvÀø¡C

¦Ü©óºC©ÊëC³Â¯lªºªvÀø¡A·¨­õ¤å»{¬°¡AÀ³µÛ­«©ó¨Ï¥Î·s«¬²Ä¤G¥N§Ü²Õ´Ói¡A¦Ó«Dµø»Ý¨DÂ_Äò¨Ï¥Î¡A¥H´î¤Ö¯e¯fÃzµo±¡§Î¡A§ïµ½¥Í¬¡«~½è¡C¥Ø«e¤wÃҹ괣¤É¦hºØ·s«¬²Ä¤G¥N§Ü²Õ´Ói (sgAH) ÃĪ«¾¯¶qªº®Ä¯q¡A¥]¬Abilastine¡Bcetirizine¡Bdesloratadine¡Bebastine¡Bfexofenadine¡B levocetirizine ©M rupatadine¡C¥Ñ©ó¨C¦ì¯f±wªºÁ{§É¤ÏÀ³»P¸gÀÙ¦Ò¶q¦³«Ü¤jªº®t¶Z¡AÂå®vÀ³®Ú¾Ú¨C¦ì¯f±w¤£¦Pªº¯fªp±Æ°£¥i¯à­P¯f¦]¤l¨Ã§´µ½³]­pªvÀø­pµe¡A¥H´Á¯à¦³®Ä±±¨î´o¤HªºëC³Â¯l¡C

¥»¤å¸g °·±dÂåÀøºô ±ÂÅv¥Zµn¡A­ì¤åµoªí©ó¦¹
¡i°·±dÂåÀøºô¡þ°OªÌªL©É«F³ø¾É¡j2022/07/18

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');